Metabolomics analysis of human cumulus cells obtained from cumulus–oocyte complexes with different developmental potential
Authors: Martínez-Moro Álvaro , González-Brusi Leopoldo , Querejeta-Fernández Ana , Padilla-Ruiz Ester , García-Blanco Javier , Bermejo-Álvarez Pablo 
Published: September 2023

STUDY QUESTION

Is the abundance of certain biochemical compounds in human cumulus cells (CCs) related to oocyte quality?

SUMMARY ANSWER

Malonate, 5-oxyproline, and erythronate were positively associated with pregnancy potential.

WHAT IS KNOWN ALREADY

CCs are removed and discarded prior to ICSI, thereby constituting an interesting biological material on which to perform molecular analysis aimed to predict oocyte developmental competence. Mitochondrial DNA content and transcriptional analyses in CC have been shown to provide a poor predictive value of oocyte competence, but the untargeted analysis of biochemical compounds (metabolomics) has been unexplored.

STUDY DESIGN, SIZE, DURATION

CCs were obtained from three groups of cumulus–oocyte complexes (COCs) of known developmental potential: oocytes not developing to blastocyst following ICSI (Bl−); oocytes developing to blastocyst but failing to establish pregnancy following embryo transfer (P−); and oocytes developing to blastocyst able to establish a pregnancy (P+). Metabolomics analyses were performed on 12 samples per group, each sample comprising the CC recovered from a single COC.

PARTICIPANTS/MATERIALS, SETTING, METHODS

Human CC samples were obtained from IVF treatments. Only unfrozen oocytes and embryos not submitted to preimplantation genetic testing were included in the analysis. Metabolomics analysis was performed by ultra-high performance liquid chromatography-tandem mass spectroscopy.

MAIN RESULTS AND THE ROLE OF CHANCE

The analysis identified 98 compounds, five of which were differentially abundant (P &lt; 0.05) between groups: asparagine, proline, and malonate were less abundant in P− compared to Bl−, malonate and 5-oxoproline were less abundant in P− group compared to P+, and erythronate was less abundant in Bl− group compared to P+. No significant association between the abundance of the compounds identified and donor age or BMI was noted.

LIMITATIONS, REASONS FOR CAUTION

Data dispersion and the lack of coherence between developmental groups preclude the direct use of metabolic markers in clinical practice, where the uterine environment plays a major role in pregnancy outcome. The abundance of other compounds not detected by the analysis may be associated with oocyte competence. As donors were lean (only two with BMI &gt; 30 kg/m2) and young (&lt;34 years old), a possible effect of obesity or advanced age on the CC metabolome could not be determined.

WIDER IMPLICATIONS OF THE FINDINGS

The abundance of malonate, 5-oxyproline, and erythronate in CC was significantly higher in COCs ultimately establishing pregnancy, providing clues on the pathways required for oocyte competence. The untargeted analysis uncovered the presence of compounds that were not expected in CC, such as β-citrylglutamate and the neurotransmitter N-acetyl-aspartyl-glutamate, which may play roles in chromatin remodeling and signaling, respectively.

STUDY FUNDING/COMPETING INTEREST(S)

Research was supported by the Industrial Doctorate Project IND2017/BIO-7748 funded by Madrid Region Government. The authors declare no competing interest.

TRIAL REGISTRATION NUMBER

N/A.